Manufacturer And Supplier 99% Crisaborole Powder CAS Number 906673-24-3 For Eczema
Product Description
Crisaborole powder is a topical medication primarily used to treat mild to moderate atopic dermatitis, commonly known as eczema. It is a phosphodiesterase-4 (PDE-4) inhibitor that works by reducing inflammation and itching associated with the condition. Crisaborole is typically applied directly to affected areas of the skin and is favored for its non-steroidal formulation, making it suitable for patients who prefer to avoid corticosteroids. It is generally well-tolerated, with few systemic side effects, and is especially useful for long-term management of eczema in both adults and children.
| Item name | Crisaborole |
| CAS No. | 906673-24-3 |
| Purity | 99% |
| Package | Aluminum Bag;Drums |
| Shipment | DHL, FedEx, TNT, UPS, Post |
| Payment Term | T/T, Western Union, L/C |
| Storage | Common storage 2-8ºC, long time storage -20ºC |
| Shelf life | 2 years |
Function and Application
Crisaborole is a phosphodiesterase 4 (PDE-4) inhibitor, although its specific mechanism of action in atopic dermatitis is not known. In the US, crisaborole is indicated for topical treatment of mild to moderate atopic dermatitis in people three months of age and older. In the EU, crisaborole is indicated for treatment of mild to moderate atopic dermatitis in people two years of age and older with ≤ 40% body surface area (BSA) affected.
